Citations

1. (2011). Analysis of candidate genes for age-related macular degeneration subtypes in the Japanese population. Mol Vis
2. (2009). Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathy. Retina
3. (2009). Association of complement factor H and LOC387715 genotypes with response of exudative agerelated macular degeneration to photodynamic therapy. Eye (Lond)
4. (2011). Association of elastin gene polymorphism to age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci
5. (2009). Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology
6. (2012). Capillary sprout endothelial cells exhibit a CD36low phenotype. Molecular Vision 2012; 18:121-127 ©
7. (2000). CD36 and atherosclerosis. Curr Opin Lipidol
8. (2008). CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodents. PLoS Med
9. (2010). CD36 plays an important role in the clearance of oxLDL and associated age-dependent subretinal deposits. Aging
10. (2003). CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3–L1 and human subcutaneous adipocytes.
11. (2001). CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.
12. (2008). Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci
13. (2011). Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum Mol Genet
14. (2009). Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture,
15. (2011). Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degeneration. Ophthalmology
16. (2008). Correlation between CFH Y402H and HTRA1 rs11200638 genotype to typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population. Clin Experiment Ophthalmol
17. (2004). Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol
18. (2000). Drugs Aging
19. (2011). Early responses to intravitreal ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
20. (2008). Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci
21. (2004). Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults the United States. Arch Ophthalmol
22. (2006). FASTSNP: an always up-todate and extendable service for SNP function analysis and prioritization. Nucleic Acids Res
23. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.
24. (2010). Genome-wide association study of advanced agerelated macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA
25. (2005). Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy. Nippon Ganka Gakkai Zasshi
26. Hyogo Macular Disease Study Group. Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a 30-month multicenter study in Hyogo,
27. (1990). Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina
28. (2003). Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics
29. (2011). Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.
30. (2011). Lipids and age-related macular degeneration. Surv Ophthalmol
31. (2011). Natural course and funduscopic findings of polypoidal choroidal vasculopathy in a Japanese population over 1 year of follow-up. Retina
32. (2008). Oxidized low density lipoproteins induce a pathologic response by retinal pigmented epithelial cells.
33. (2010). Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population. Ophthalmology
34. (2001). Photodynamic therapy of age-related macular degeneration: History and principles. Semin Ophthalmol
35. (2010). Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res
36. (2009). Positive Association of Common Variants in CD36 with Neovascular Age-Related Macular Degeneration. Aging
37. (2011). Positive association of complement factor H gene variants with the effect of photodynamic therapy in polypoidal choroidal vasculopathy. J Clinic Experiment Ophthalmol.
38. (2001). Retinal angiomatous proliferation in agerelated macular degeneration. Retina
39. (2007). Scavenger receptors for oxidized lipoprotein in age-related macular degeneration. Invest Ophthalmol Vis Sci
40. (2008). Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel. Mol Vis
41. (2011). The association of ARMS2 polymorphisms with phenotype in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
42. (1990). The posterior uveal bleeding syndrome. Retina
43. (2000). The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol
44. (2009). Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress. Clin Lipidol.
45. (2008). Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet
46. (2009). Vision Health Cost-Effectiveness Study Group. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.